Top

Gepubliceerd in:

01-05-2014 | Original Paper

Use of Psychotropic Medications Among Youth in Treatment Foster Care

Auteurs: Sharon L. Brenner, Dannia G. Southerland, Barbara J. Burns, H. Ryan Wagner, Elizabeth M. Z. Farmer

Gepubliceerd in: Journal of Child and Family Studies | Uitgave 4/2014

Abstract

We describe the use of psychotropic medications among youth in treatment foster care (TFC). Data from 240 youth were coded to examine rates of medication use, including polypharmacy and an indicator of “questionable polypharmacy.” Fifty-nine percent of youth in TFC had taken a psychotropic medication within the past 2 months. Of the youth taking psychotropics, 61 % took two or more and 22 % met criteria for questionable polypharmacy. The majority of youth taking psychotropics also received psychosocial mental health services and were more likely to receive such services than youth not taking medication. Use of psychotropic medication use was not significantly related to demographic factors, maltreatment history, or custody. However, youth with more severe symptoms were more likely to be on medications and to be on multiple medications. Youth with “questionable polypharmacy” were less likely than other youth on multiple medications to have a recent visit to a psychiatrist.

vorige artikel Outpatient Psychotropic Medication Use in the US: A Comparison Based on Foster Care Status

volgende artikel Reducing Psychotropic Medications in an Intensive Residential Treatment Center

Ascher, B. H., Farmer, E. M. Z., Burns, B. J., & Angold, A. (1996). The child and adolescent services assessment (CASA): Description and psychometrics. Journal of Emotional and Behavioral Disorders, 4, 12–20.CrossRef

Bentley, K. J., & Collins, K. S. (2013). Psychopharmacological treatment for child and adolescent mental disorders. In C. Franklin, M. S. Harris, & P. A. Mears (Eds.), The school services sourcebook (2nd ed.). NY: Oxford.

Bourdon, K. H., Goodman, R., Rae, D. S., Simpson, G., & Koretz, D. S. (2005). The Strengths and Difficulties Questionnaire: US normative data and psychometric properties. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 557–564.PubMedCrossRef

Boyer, E. W., & Shannon, M. (2005). The serotonin syndrome. New England Journal of Medicine, 352, 1112–1120.PubMedCrossRef

Breland-Noble, A. M., Elbogen, E. B., Farmer, E. M. Z., Dubs, M. S., Wagner, H. R., & Burns, B. J. (2004). Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatric Services, 55, 706–708.PubMedCrossRef

Breland-Noble, A. M., Farmer, E. M. Z., Dubs, M. S., Potter, E., & Burns, B. J. (2005). Mental health and other service use by youth in therapeutic foster care and group homes. Journal of Child and Family Studies, 14, 167–180.CrossRef

Brown, R., & Sammons, M. T. (2002). Pediatric psychopharmacology: A review of new developments and recent research. Professional Psychology—Research and Practice, 33, 135–147.CrossRef

Burns, B. J., Hoagwood, K., & Mrazek, P. J. (1999). Effective treatment for mental disorders in children and adolescents. Clinical Child and Family Psychology Review, 2, 199–253.PubMedCrossRef

Bussing, R., Mason, D. M., Leon, C. E., & Sinha, K. (2003). Agreement between CASA parent reports and provider records of children’s ADHD services. Journal of Behavioral Health Services and Research, 30, 462–469.PubMedCrossRef

Chen, H., Reeves, J. H., Fincham, J. E., Kennedy, W. K., Dorfman, J. H., & Martin, B. C. (2006). Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia Medicaid enrollees in 2001. Journal of Clinical Psychiatry, 67, 972–982.PubMedCrossRef

Comer, J. S., Olfson, M., & Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. American Academy of Child and Adolescent Psychiatry, 49, 1001–1010.CrossRef

Connor, D. F., Ozbayrak, K. R., Harrison, R. J., & Melloni, R. H. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of Child and Adolescent Psychopharmacology, 8, 27–38.PubMedCrossRef

Constantine, R. J., Boaz, T., & Tandon, R. (2010). Antipsychotic polypharmacy in the treatment of children and adolescents in the fee-for-service component of a large state Medicaid program. Clinical Therapeutics, 32, 949–959.PubMedCrossRef

Crismon, M. L., & Argo, T. (2009). The use of psychotropic medication for children in foster care. Child Welfare, 88, 71–100.PubMed

Dean, A. J., McDermott, B. M., & Marshall, R. T. (2006). Psychotropic medication utilization in a child and adolescent mental health service. Journal of Child and Adolescent Psychopharmacology, 16, 273–285.PubMedCrossRef

dosReis, S., Zito, J. M., Safer, D. J., Gardner, J. F., Puccia, K. B., & Owens, P. L. (2005). Multiple psychotropic medication use for youths: A two-state comparison. Journal of Child and Adolescent Psychopharmacology, 15, 68–77.PubMedCrossRef

Essock, S. M., Covell, N. H., Leckman-Westin, E., Lieberman, J. A., Sederer, L. I., Kealyey, E., et al. (2009). Identifying questionable psychotropic prescribing practices for Medicaid recipients in New York State. Psychiatric Services, 60, 1595–1602.PubMedCrossRef

Farmer, E. M. Z., Angold, A., Burns, B. J., & Costello, E. J. (1994). Reliability of self-reported service use: Test–retest consistency of children’s responses to the child and adolescent services assessment. Journal of Child and Family Studies, 3, 307–325.CrossRef

Farmer, E. M. Z., Burns, B. J., Dubs, M. S., & Thompson, S. (2002). Assessing conformity to standards for treatment foster care. Journal of Emotional and Behavioral Disorders, 10, 213–222.

Farmer, E. M. Z., Burns, B. J., Wagner, H. R., Murray, M., & Southerland, D. G. (2010a). Enhancing “usual practice” treatment foster care: Findings from a randomized trial on improving youths’ outcomes. Psychiatric Services, 61, 555–561.PubMedCentralPubMedCrossRef

Farmer, E. M. Z., Mustillo, S. A., Wagner, H. R., Burns, B. J., Kolko, D. J., Barth, R. P., et al. (2010b). Service use and multi-sector use for mental health problems by youth in contact with child welfare. Children and Youth Services Review, 32, 815–821.CrossRef

Ferguson, D. G., Glesener, D. C., & Raschick, M. (2006). Psychotropic drug use with European American and American Indian children in foster care. Journal of Child and Adolescent Psychopharmacology, 16, 474–481.PubMedCrossRef

Findling, R. L., Johnson, J. L., McClellan, J., Frazier, J. A., Vitiello, B., Hamer, R. M., et al. (2010). Double-blind maintenance safety and effectiveness findings from the treatment of early-onset schizophrenia spectrum (TEOSS) study. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 583–594.PubMedCentralPubMed

Fontanella, C. A., Bridge, J. A., & Campo, J. V. (2009). Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients. Annals of Pharmacotherapy, 43, 1939–1947.PubMedCrossRef

Goodman, R. (2001). Psychometric properties of the Strengths and Difficulties Questionnaire. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1337–1345.PubMedCrossRef

Goodman, R., Ford, T., Simmons, H., Gatward, R., & Meltzer, H. (2000). Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. British Journal of Psychiatry, 177, 534–539.PubMedCrossRef

Huefner, J. C., Griffith, A. K., Smith, G. L., Vollmer, D. G., & Leslie, L. K. (2012). Reducing psychotropic medications in an intensive residential treatment center. Journal of Child and Family Studies, 1–11.

Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 557–565.PubMedCrossRef

Jerrell, J. M. (2009). Neurological and cardiovascular adverse events associated with antimanic treatment in children and adolescents. CNS Neuroscience and Therapeutics, 16, 25–31.PubMedCrossRef

Jerrell, J. M., & McIntyre, R. S. (2008). Adverse events in children and adolescents treated with antipsychotic medications. Human Psychopharmacology Clinical and Experimental, 23, 283–290.PubMedCrossRef

Leslie, L. K., Mackie, T., Dawson, E. H., Bellonci, C., Schoonover, D. R., Rodday, A. M., et al. (2010). Multi-state study on psychotropic medication oversight in foster care. Boston, MA: Clinical and Translational Sciences Institute, Tufts University Medical Center.

Malone, R. P., Sheikh, R., & Zito, J. M. (1999). Novel antipsychotic medications in the treatment of children and adolescents. Psychiatric Services, 50, 171–174.PubMed

Mark, T. L., Levit, K. R., & Buck, J. A. (2009). Psychotropic drug prescriptions by medical specialty. Psychiatric Services, 60, 1167.PubMedCrossRef

Mojtabai, R., & Olson, M. (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry, 67, 26–36.PubMedCrossRef

Morrato, E. H., Nicol, G. E., Maahs, D., Druss, B. G., Hartung, D. M., Valuck, R. J., et al. (2010). Metabolic screening in children receiving antipsychotic drug treatment. Archives of Pediatrics and Adolescent Medicine, 164, 344–351.PubMedCrossRef

Murray, M. M., Southerland, D., Farmer, E. M., & Ballentine, K. (2010). Enhancing and adapting treatment foster care: Lessons learned in trying to change practice. Journal of Child and Family Studies, 19, 393–403.PubMedCentralPubMedCrossRef

Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63, 679–685.PubMedCrossRef

Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 13–23.PubMed

Olfson, M., & Marcus, S. C. (2010). National trends in outpatient psychotherapy. American Journal of Psychiatry, 167, 1456–1463.PubMedCrossRef

Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514–521.PubMedCrossRef

Riddle, M. A., Kastelic, E. A., & Frosch, E. (2001). Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry, 42, 73–90.PubMedCrossRef

Rushton, J. L., & Whitmire, J. T. (2001). Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends, 1992 to 1998. Archives of Pediatrics and Adolescent Medicine, 155, 560–565.PubMedCrossRef

Ryan, J. B., Reid, R., Gallagher, K., & Ellis, C. (2008). Prevalence rates of psychotropic medications for students placed in residential facilities. Behavioral Disorders, 33, 99–107.

Safer, D. J., Zito, J. M., & dosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160, 438–449.PubMedCrossRef

StataCorp. (2009). Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.

Swanson, J., Arnold, L. E., Kraemer, H., Hechtman, L., Molina, B., Hinshaw, S., et al. (2008). Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children with ADHD (MTA)—Part II: Supporting details. Journal of Attention Disorders, 12, 15–43.PubMedCrossRef

Treatment for Adolescents with Depression Study (TADS) Team. (2007). The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64, 1132–1144.CrossRef

Walkup, J. T., Albano, A. M., Piacentini, J., Bimaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–2766.PubMedCentralPubMedCrossRef

Walkup, J., & The AACAP Work Group on Quality Issues. (2009). Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 961–973.CrossRef

Zima, B. T., Bussing, R., Crecelius, G. M., Kaufman, A., & Belin, T. R. (1999). Psychotropic medication treatment patterns among school-aged children in foster care. Journal of Child and Adolescent Psychopharmacology, 9, 135–147.PubMedCrossRef

Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., et al. (2003). Psychotropic patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17–25.PubMedCrossRef

Zito, J. M., Safer, D. J., Sai, D., Gardner, J. F., Thomas, D., Coombes, P., et al. (2008). Psychotropic medication patterns among youth in foster care. Pediatrics, 121, e157–e163.PubMedCrossRef

Zito, J. M., Safer, D. J., Valluri, S., Gardner, J. F., Korelitz, J. J., & Mattison, D. R. (2007). Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology, 17, 195–203.PubMedCrossRef

Titel: Use of Psychotropic Medications Among Youth in Treatment Foster Care
Auteurs: Sharon L. Brenner
Dannia G. Southerland
Barbara J. Burns
H. Ryan Wagner
Elizabeth M. Z. Farmer
Publicatiedatum: 01-05-2014
Uitgeverij: Springer US
Gepubliceerd in: Journal of Child and Family Studies / Uitgave 4/2014
Print ISSN: 1062-1024
Elektronisch ISSN: 1573-2843
DOI: https://doi.org/10.1007/s10826-013-9882-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2014

Service and Medication Use and Their Effects on Arrest Rates Among Children with Emotional Disturbances Before Disenrollment from Medicaid

Psychotropic Medication Management Within Residential Treatment Centers: Physician Opinions About Difficulties and Barriers

A Model of Pediatric Psychopharmacology-Psychotherapy Treatment Integration in the Ambulatory Clinical Setting

Outpatient Psychotropic Medication Use in the US: A Comparison Based on Foster Care Status

Review of State Medication Policies/Guidelines Regarding Psychotropic Medications in Public Schools

Psychotropic Medication Patterns in Medicaid-Insured Youth Based on Clinician-Reported Maltreatment Status